Structure Therapeutics Chief Commercial Officer John Joseph Berrios files initial beneficial ownership statement
GPCR•Form 3 filing for Chief Commercial Officer
- Structure Therapeutics filed a Form 3 for Chief Commercial Officer John Joseph Berrios, disclosing his initial insider holdings as of Aug. 6, 2026.
